DEERFIELD, Ill. — Net earnings at Walgreen Co. fell by 25% to $413 million in the fiscal first quarter as a result of declines in prescription volume and front-end sales as well as shifts to generic drugs. Walgreen said prescription sales decreased by 7.2% compared with the first quarter last year, but rebounded from an 8% drop in the fourth quarter, indicating some recovery as a result of a settlement reached over the summer with pharmacy benefits manager Express Scripts. ...
REGISTER TO VIEW THIS ARTICLE - Register for a Free Account
Why Register for FREE?
Registering for content on Supermarket News will give you INSTANT access to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’s FREE, easy and quick. What are you waiting for! In addition you will also receive a complimentary copy of SN's salary survey sent to you by email.
Attention Paid Print Subscribers: While you have already been granted free access to SN we ask that you register now. We promise it will only take a few minutes! Or visit your profile and add your print magazine account number and zip code.